Cargando…

Hydroxychloroquine for COVID-19: Balancing contrasting claims

Detalles Bibliográficos
Autores principales:	Horby, Peter W., Emberson, Jonathan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682326/ https://www.ncbi.nlm.nih.gov/pubmed/33243609 http://dx.doi.org/10.1016/j.ejim.2020.11.018

Ejemplares similares

Does hydroxychloroquine reduce mortality for COVID-19?
por: GALLUS, Silvano, et al.
Publicado: (2020)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
por: Hennekens, Charles H., et al.
Publicado: (2022)

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness
por: Cavalli, Giulio, et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
por: Okour, Malek, et al.
Publicado: (2020)

Risk of using hydroxychloroquine as a treatment of COVID-19
por: Alanagreh, Lo’ai, et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned
por: Udupa, Akrithi, et al.
Publicado: (2021)

Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?
por: Lekpa, Fernando Kemta, et al.
Publicado: (2021)

Hydroxychloroquine: balancing the needs of LMICs during the COVID-19 pandemic
por: Banerjee, Soumya
Publicado: (2020)

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy
por: Scherrmann, JM.
Publicado: (2020)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19
por: Sandercock, Peter A. G., et al.
Publicado: (2022)

Within a large healthcare system, the incidence of positive COVID-19 results and mortality are lower in patients on chronic hydroxychloroquine therapy
por: Sen, Soma, et al.
Publicado: (2020)

Has the door closed on hydroxychloroquine for SARS-COV-2?
por: Paul, Mical
Publicado: (2021)

Commentary: On the reliability of causal claims
por: Weed, Douglas L.
Publicado: (2022)

Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment
por: Seligmann, Hervé
Publicado: (2021)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence
por: Bigna, Jean Joel, et al.
Publicado: (2020)

A challenge to claims for mycorrhizal-transmitted wound signaling
por: Blatt, Michael R., et al.
Publicado: (2023)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

From hydroxychloroquine to ivermectin: how unproven “cures” can go viral
por: Taccone, Fabio Silvio, et al.
Publicado: (2022)

Prostate Cancer Claims for a Personalized Medicine
por: Lazzeri, Massimo
Publicado: (2015)

Extraordinary claims, extraordinary evidence? A discussion
por: Shiffrin, Richard M., et al.
Publicado: (2021)

Allocated but not treated: the silent 16% – Authors' reply
por: Horby, Peter, et al.
Publicado: (2022)

Using Medical Claims Analyses to Understand Interventions for Parkinson Patients
por: Bloem, Bastiaan R., et al.
Publicado: (2018)

Chiropractic students call for action against unsubstantiated claims
por: Plener, Joshua, et al.
Publicado: (2020)

Patient reported outcomes: looking beyond the label claim
por: Doward, Lynda C, et al.
Publicado: (2010)

The group selection–inclusive fitness equivalence claim: not true and not relevant
por: van Veelen, Matthijs
Publicado: (2020)

An Appetite for Modernizing the Regulatory Framework for Protein Content Claims in Canada
por: Marinangeli, Christopher P. F., et al.
Publicado: (2017)

Ketone body supplement label claims: what supplement has been supplemented?
por: Da Costa, D, et al.
Publicado: (2019)

No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2
por: Liu, Shan-Lu, et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: The endgame!
por: Deplanque, Dominique
Publicado: (2023)

Towards a socially just model: balancing hunger and response to the COVID-19 pandemic in Bangladesh
por: Rashid, Sabina Faiz, et al.
Publicado: (2020)

Call for comments: climate and clean air responses to covid-19
por: Agrawala, Shardul, et al.
Publicado: (2020)

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
por: Geleris, Joshua, et al.
Publicado: (2020)

Cancer has not gone away: A primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19
por: Helsper, Charles W., et al.
Publicado: (2020)

ChemBank Coming Soon and the Latest Great Flood Claims Research
por: Haley, Shauna
Publicado: (2001)

Non-inferiority versus superiority drug claims: the (not so) subtle distinction
por: Ganju, Jitendra, et al.
Publicado: (2017)

How overstated scientific claims undermine ethical principles in parenting interventions
por: Scheidecker, Gabriel, et al.
Publicado: (2021)

Rasch Measurement and Patient Reported Value Claims: A Primer for Hemophilia
por: Langley, Paul C
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ppf4it75mjmg8sd9uvegd9oah7